Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Sinan Khayyat"'
Publikováno v:
Cardiovascular Revascularization Medicine. 21:73-76
Cardiac blood cysts are very rare in adults. Their etiology, pathogenesis, and optimal management remain unclear. We report a case of a large left atrial cystic mass with clinical and imaging characteristics of a blood cyst that vanished between ches
Publikováno v:
Circulation. 141
Introduction: The prevalence of obesity in the US is 41.1% and is on the rise. Data are limited and results are mixed on the effect of body mass index (BMI) on outcomes of transcatheter aortic valve replacement (TAVR). The objective of this study was
Publikováno v:
Expert Review of Cardiovascular Therapy. 17:237-239
Not all diabetic patients should be routinely started on statin therapy regardless of serum cholesterol level. Current American College of Cardiology (ACC), American Heart Association (AHA) and Ame...
Publikováno v:
Stroke. 50
Background: End-stage renal disease patients undergoing dialysis have higher stroke risk causing significant comorbidity and mortality in patients undergoing cardiac surgery procedures. Transcatheter aortic valve replacement(TAVR) has been approved b
Publikováno v:
Cardiovascular revascularization medicine : including molecular interventions. 20(10)
Dialysis is associated with higher rate of aortic valve calcification and higher cardiovascular mortality. Transcatheter aortic valve replacement (TAVR) is an established alternative for surgical aortic valve replacement (SAVR) in patients with highe
Autor:
Paul M Ndunda, Tabitha Muutu, Sachin Srinivasan, Sinan Khayyat, Zaher Fanari, Mohinder Vindhyal
Publikováno v:
Circulation. 138
Introduction: Stroke is still a major complication that is reported in 2-5% of patients at 30 days, after a transcatheter aortic valve replacement (TAVR). The Sentinel Cerebral Protection System (CPS) (Claret Medical Inc., Santa Rosa, CA. USA) is the
Publikováno v:
Cureus
Introduction Heart failure (HF) is one of the most common causes of hospitalization and readmissions. Approximately six million Americans are living with HF. Among patients with HF, hospitalization rate in the United States is higher for those over a
Publikováno v:
JACC: Cardiovascular Interventions. 12:S39-S40
Clinical outcomes of drug-eluting stents (DES) in coronary artery disease have improved, but concerns about stent neo-atherosclerosis, thrombosis, and restenosis remain. The COMBO dual therapy stent (COMBO DTS) is a sirolimus-eluting stent with CD34
Publikováno v:
Kansas Journal of Medicine
Antiphospholipid syndrome (APS) is a multisystem autoimmune disorder characterized by arterial or venous thrombosis and pregnancy morbidity in the presence of antiphospholipid antibodies (aPL).1 It can be primary or secondary. Primary antiphospholipi
Publikováno v:
JACC: Cardiovascular Interventions. 12:S51-S52
Studies suggest an association between transthyretin-related cardiac amyloidosis (ATTR CA) and calcific aortic stenosis (AS). The prevalence of cardiac amyloidosis in patients undergoing transcatheter aortic valve replacement (TAVR) and surgical aort